Romilda Cardin

University of Padua — Italy

Medicine · Health Sciences

30h-index3.2kcitations140works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(30), Helicobacter pylori-related gastroenterology studies(22), Hepatocellular Carcinoma Treatment and Prognosis(20), Eosinophilic Esophagitis(14), Hepatitis C virus research(13)

Publications140 total

Could modulating the esophageal microbiome be the answer for eosinophilic esophagitis treatment?
Expert Review of Gastroenterology & Hepatology·2025· 3 cited
OC.10.4 SOMATIC COPY NUMBER ALTERATIONS IN CIRCULATING CELL-FREE DNA AS A PREDICTIVE BIOMARKER FOR HEPATOCELLULAR CARCINOMA: INSIGHTS FROM A PROOF-OF-CONCEPT STUDY
Digestive and Liver Disease·2025
Activation of the Contact System and Intrinsic Pathway in Peripheral and Portal Venous Circulations in Liver Cirrhosis
Thrombosis and Haemostasis·2024· 1 cited
Drug-Induced Liver Injury: Role of Circulating Liver-Specific microRNAs and Keratin-18
Gastroenterology Insights·2024· 2 citedOpen Access
HIF-1α and VEGF as prognostic biomarkers in hepatocellular carcinoma patients treated with transarterial chemoembolization
Digestive and Liver Disease·2023· 28 citedOpen Access
Autoimmune Atrophic Gastritis: The Role of miRNA in Relation to Helicobacter Pylori Infection
Frontiers in Immunology·2022· 13 citedOpen Access
AF.56 COMPARATIVE ASSESSMENT OF INFLIXIMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Digestive and Liver Disease·2021
AF.48 COMPARATIVE ASSESSMENT OF ADALIMUMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Digestive and Liver Disease·2021Open Access
OC.04.6 CIRCULATING PROSTAGLANDIN E2: A NOVEL POTENTIAL PROGNOSTIC BIOMARKER IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
Digestive and Liver Disease·2021
Circulating MicroRNA-21 and MicroRNA-122 as Prognostic Biomarkers in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
Biomedicines·2021· 20 citedOpen Access
Liquid Biopsy in Hepatocellular Carcinoma: Where Are We Now?
Cancers·2021· 43 citedOpen Access
P329 Comparative Assessment of Adalimumab Trough Levels between Point-of-Care Testing and current Standard of Care (enzyme linked immunosorbent assay) in patients with Inflammatory Bowel Disease
Journal of Crohn s and Colitis·2021
P295 Comparative Assessment of Infliximab Trough Levels between Point-of-Care Testing and current Standard of Care (enzyme linked immunosorbent assay) in patients with Inflammatory Bowel Disease
Journal of Crohn s and Colitis·2021Open Access
Circulating prostaglandin E2: a novel potential prognostic biomarker in patients with hepatocellular carcinoma
Clinical and Experimental Medicine·2021· 5 cited
Coffee and hepatocellular carcinoma: epidemiologic evidence and biologic mechanisms
Hepatoma Research·2021· 4 citedOpen Access
Rapid point-of-care anti-infliximab antibodies detection in clinical practice: comparison with ELISA and potential for improving therapeutic drug monitoring in IBD patients
Therapeutic Advances in Gastroenterology·2021· 22 citedOpen Access
Switching from Infliximab Originator to SB2 Biosimilar in Inflammatory Bowel Diseases: A Multicentric Prospective Real-Life Study
Therapeutic Advances in Gastroenterology·2021· 12 citedOpen Access
OC.05.1 MICRORNA-21 AND MICRORNA-122: PROGNOSIS PREDICTION AND CORRELATION WITH HIF-1ALPHA IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH TRANSARTERIAL CHEMOEMBOLIZATION
Digestive and Liver Disease·2020· 1 cited
OC.05.6 GENDER-RELATED DIFFERENCES IN SCCA-IGM LEVELS IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH TRANSARTERIAL CHEMOEMBOLIZATION
Digestive and Liver Disease·2020
Endothelial portal venous damage is associated with alterations in local TM and EPCR expression in patients with cirrhosis and portal hypertension
Journal of Hepatology·2020Open Access
page 1 of 7Next →

Frequent Co-authors

Fabio Farinati(41), R. Naccarato(17), Massimo Rugge(11), Mario Plebani(9), Marina Bortolami(9), Umberto Cillo(8), László Herszényi(8), Patrizia Burra(7), Massimo De Paoli(7), M. Piciocchi(7), Paolo Carraro(6), Giovanni Roveroni(5), Francesco Di Mario(4), Nicola De Maria(4), Zsolt Tulassay(4), Antonietta D’Errico(4), A. Cecchetto(4), Donato Nitti(4), Francesco Paolo Russo(4), Alessandro Vitale(4)